SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma

NCT02807181 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

89

Enrollment

INDUSTRY

Sponsor class

Stopped Slow enrollment

Conditions

Intrahepatic Cholangiocarcinoma

Interventions

DRUG: Cisplatin-gemcitabine
DEVICE: Radiation: SIRT + chemotherapy (cisplatin-gemcitabine)

Sponsor

Sirtex Medical